Recent Advances in Alzheimer's Treatment and Its Impact

This chapter presents recent advancements in Alzheimer's disease therapies, particularly the new medication LACMAP that targets beta-amyloid to slow disease progression. It also discusses the approval process in the U.S. and China, and the implications of limited access to this treatment for families affected by Alzheimer's.